Amyotrophic Lateral Sclerosis Research Program


U.S. Department of Defense - Congressionally Directed Medical Research Programs (CDMRP) 


The Fiscal Year 2021 (FY21) Defense Appropriations Bill has not been signed into law.  Although FY21 funds have not been appropriated, the CDMRP is providing information to allow investigators time to plan and develop ideas for submission to the anticipated FY21 funding opportunities.  The following FY21 funding opportunities are anticipated:

Amyotrophic Lateral Sclerosis Research Program (ALSRP)

  • Therapeutic Idea Award
  • Therapeutic Development Award
  • Clinical Development Award
  • New in FY21! Therapeutic/Biomarker Pilot Trial Award

Descriptions of each of the anticipated funding opportunities, eligibility, key mechanism elements, and funding can be found in the Program pre-announcements.  FY21 pre-announcements can be found in the CDMRP home page features.  Subsequent notifications will be sent when the program announcements/funding opportunities are released.

If you are considering applying to this program, please contact Angela Vuk to review program requirements.

Special Notes

Please note that research activities carried out in the context of COVID-19 need to adhere to the University of Guelph COVID-19 research principles, policies, guidelines and processes as they may be updated from time to time and communicated on the Office of Research web-page.

For Questions, please contact

Office of Research

Angela Vuk, Senior Grants and Contracts Specialist
Research Services Office
519-824-4120 x55026

Alert Classifications
Funding Opportunities and Sponsor News

Health and Life Sciences
Information and Communications Technology
Physical Sciences and Engineering
Social Sciences